1-anilino-8-naphthalenesulfonate has been researched along with Dyslipidemias in 41 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rats were exposed to 1 or 10 μg/mL bisphenol A (BPA) in water during pregnancy and lactation." | 3.83 | Effect of Perinatal Bisphenol A Exposure on Serum Lipids and Lipid Enzymes in Offspring Rats of Different Sex. ( Gao, L; Jia, LH; Jia, Y; Peng, FY; Wang, HN; Wei, W; Zhang, L, 2016) |
| "Epidemiological studies indicate that NAFLD raises risk of fatal or non-fatal CVD events." | 2.72 | Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches. ( Corsini, A; Dongiovanni, P; Paolini, E; Ruscica, M; Sirtori, CR, 2021) |
| "Nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are highly prevalent, affecting approximately one-third of the US population." | 2.58 | Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. ( Kim, D; Kim, WR; Touros, A, 2018) |
| "Nephrotic syndrome is a highly prevalent disease that is associated with high morbidity despite notable advances in its treatment." | 2.58 | Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. ( Agrawal, S; Fornoni, A; Smoyer, WE; Zaritsky, JJ, 2018) |
| "Obesity is a disease that develops as a result of long-term positive energy balance." | 2.50 | [The role of gut microbiota in the pathogenesis of obesity]. ( Chudek, J; Kocełak, P; Olszanecka-Glinianowicz, M; Zak-Gołąb, A, 2014) |
| "Tangeretin treatment of hepatic cells also reduced the levels of both intracellular and secreted ANGPTL3 proteins." | 1.62 | The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells. ( Chao, TY; Chen, PY; Gao, WY; Hsu, HJ; Lin, CY; Wang, CY; Wu, MJ; Yen, JH, 2021) |
| "The association between nonalcoholic fatty liver disease (NAFLD) and apolipoprotein C3 gene (APOC3) promoter region single-nucleotide polymorphisms (SNPs) rs2854117 and rs2854116 is controversial." | 1.43 | APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases. ( Chen, GY; Fan, JG; Mi, YQ; Pan, Q; Shen, F; Zhang, RN; Zheng, RD; Zhou, D; Zhu, CY, 2016) |
| " Chronic administration of REGN1500 to dyslipidemic C57Bl/6 mice for 8 weeks reduced circulating plasma levels of TG, LDL-cholesterol (LDL-C), and HDL-cholesterol (HDL-C) without any changes in liver, adipose, or heart TG contents." | 1.42 | ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys. ( Alexa, CA; Buckler, D; Cohen, JC; Gromada, J; Gusarova, V; Hobbs, HH; Kim, JH; Mintah, IJ; Murphy, AJ; Rafique, A; Shihanian, LM; Valenzuela, DM; Wang, Y; Xin, Y; Yancopoulos, GD, 2015) |
| "Genetic risk ratios for type 2 diabetes for a 0." | 1.42 | HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study. ( Frikke-Schmidt, R; Haase, CL; Nordestgaard, BG; Tybjærg-Hansen, A, 2015) |
| "Ezetimibe is a lipid-lowering agent that inhibits the intestinal absorption of cholesterol and other related phytosterols." | 1.34 | Ezetimibe-induced acute pancreatitis. ( Ahmad, I; Hotiana, M; Hussain, M; Rahman, F; Ruby, E; Usman, H, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (24.39) | 29.6817 |
| 2010's | 28 (68.29) | 24.3611 |
| 2020's | 3 (7.32) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PY | 1 |
| Chao, TY | 1 |
| Hsu, HJ | 1 |
| Wang, CY | 1 |
| Lin, CY | 1 |
| Gao, WY | 1 |
| Wu, MJ | 1 |
| Yen, JH | 1 |
| Fukaishi, T | 1 |
| Minami, I | 1 |
| Masuda, S | 1 |
| Miyachi, Y | 1 |
| Tsujimoto, K | 1 |
| Izumiyama, H | 1 |
| Hashimoto, K | 1 |
| Yoshida, M | 1 |
| Takahashi, S | 1 |
| Kashimada, K | 1 |
| Morio, T | 1 |
| Kosaki, K | 1 |
| Maezawa, Y | 1 |
| Yokote, K | 1 |
| Yoshimoto, T | 1 |
| Yamada, T | 1 |
| Dongiovanni, P | 1 |
| Paolini, E | 1 |
| Corsini, A | 1 |
| Sirtori, CR | 1 |
| Ruscica, M | 1 |
| Kim, D | 1 |
| Touros, A | 1 |
| Kim, WR | 1 |
| Agrawal, S | 1 |
| Zaritsky, JJ | 1 |
| Fornoni, A | 1 |
| Smoyer, WE | 1 |
| Yang, S | 1 |
| Yin, RX | 1 |
| Miao, L | 1 |
| Zhou, YG | 1 |
| Wu, J | 1 |
| Zhang, QH | 1 |
| Kratky, D | 1 |
| Obrowsky, S | 1 |
| Kolb, D | 1 |
| Radovic, B | 1 |
| Elshourbagy, NA | 1 |
| Meyers, HV | 1 |
| Abdel-Meguid, SS | 1 |
| Zak-Gołąb, A | 1 |
| Olszanecka-Glinianowicz, M | 1 |
| Kocełak, P | 1 |
| Chudek, J | 1 |
| Lange, LA | 1 |
| Hu, Y | 1 |
| Zhang, H | 1 |
| Xue, C | 1 |
| Schmidt, EM | 1 |
| Tang, ZZ | 1 |
| Bizon, C | 1 |
| Lange, EM | 1 |
| Smith, JD | 1 |
| Turner, EH | 1 |
| Jun, G | 1 |
| Kang, HM | 1 |
| Peloso, G | 1 |
| Auer, P | 1 |
| Li, KP | 1 |
| Flannick, J | 1 |
| Zhang, J | 1 |
| Fuchsberger, C | 1 |
| Gaulton, K | 1 |
| Lindgren, C | 1 |
| Locke, A | 1 |
| Manning, A | 1 |
| Sim, X | 1 |
| Rivas, MA | 1 |
| Holmen, OL | 1 |
| Gottesman, O | 1 |
| Lu, Y | 1 |
| Ruderfer, D | 1 |
| Stahl, EA | 1 |
| Duan, Q | 1 |
| Li, Y | 1 |
| Durda, P | 1 |
| Jiao, S | 1 |
| Isaacs, A | 1 |
| Hofman, A | 1 |
| Bis, JC | 1 |
| Correa, A | 1 |
| Griswold, ME | 1 |
| Jakobsdottir, J | 1 |
| Smith, AV | 1 |
| Schreiner, PJ | 1 |
| Feitosa, MF | 2 |
| Zhang, Q | 1 |
| Huffman, JE | 1 |
| Crosby, J | 1 |
| Wassel, CL | 1 |
| Do, R | 1 |
| Franceschini, N | 1 |
| Martin, LW | 1 |
| Robinson, JG | 1 |
| Assimes, TL | 1 |
| Crosslin, DR | 1 |
| Rosenthal, EA | 1 |
| Tsai, M | 1 |
| Rieder, MJ | 1 |
| Farlow, DN | 1 |
| Folsom, AR | 1 |
| Lumley, T | 1 |
| Fox, ER | 1 |
| Carlson, CS | 1 |
| Peters, U | 1 |
| Jackson, RD | 1 |
| van Duijn, CM | 1 |
| Uitterlinden, AG | 1 |
| Levy, D | 1 |
| Rotter, JI | 1 |
| Taylor, HA | 1 |
| Gudnason, V | 1 |
| Siscovick, DS | 1 |
| Fornage, M | 1 |
| Borecki, IB | 2 |
| Hayward, C | 1 |
| Rudan, I | 1 |
| Chen, YE | 1 |
| Bottinger, EP | 1 |
| Loos, RJ | 1 |
| Sætrom, P | 1 |
| Hveem, K | 1 |
| Boehnke, M | 1 |
| Groop, L | 1 |
| McCarthy, M | 1 |
| Meitinger, T | 1 |
| Ballantyne, CM | 1 |
| Gabriel, SB | 1 |
| O'Donnell, CJ | 1 |
| Post, WS | 1 |
| North, KE | 1 |
| Reiner, AP | 1 |
| Boerwinkle, E | 1 |
| Psaty, BM | 1 |
| Altshuler, D | 1 |
| Kathiresan, S | 1 |
| Lin, DY | 1 |
| Jarvik, GP | 1 |
| Cupples, LA | 1 |
| Kooperberg, C | 1 |
| Wilson, JG | 1 |
| Nickerson, DA | 1 |
| Abecasis, GR | 1 |
| Rich, SS | 1 |
| Tracy, RP | 1 |
| Willer, CJ | 1 |
| Ferrer, R | 1 |
| Pardina, E | 1 |
| Rossell, J | 1 |
| Baena-Fustegueras, JA | 1 |
| Lecube, A | 1 |
| Balibrea, JM | 1 |
| Caubet, E | 1 |
| González, O | 1 |
| Vilallonga, R | 1 |
| Fort, JM | 1 |
| Peinado-Onsurbe, J | 1 |
| Gusarova, V | 1 |
| Alexa, CA | 1 |
| Wang, Y | 1 |
| Rafique, A | 1 |
| Kim, JH | 1 |
| Buckler, D | 1 |
| Mintah, IJ | 1 |
| Shihanian, LM | 1 |
| Cohen, JC | 1 |
| Hobbs, HH | 1 |
| Xin, Y | 1 |
| Valenzuela, DM | 1 |
| Murphy, AJ | 1 |
| Yancopoulos, GD | 1 |
| Gromada, J | 1 |
| Haase, CL | 1 |
| Tybjærg-Hansen, A | 1 |
| Nordestgaard, BG | 1 |
| Frikke-Schmidt, R | 1 |
| Guardiola, M | 1 |
| Echeverria, P | 1 |
| González, M | 1 |
| Vallvé, JC | 1 |
| Puig, J | 1 |
| Clotet, B | 1 |
| Ribalta, J | 1 |
| Negredo, E | 1 |
| Andrés-Blasco, I | 1 |
| Herrero-Cervera, A | 1 |
| Vinué, Á | 1 |
| Martínez-Hervás, S | 1 |
| Piqueras, L | 1 |
| Sanz, MJ | 1 |
| Burks, DJ | 1 |
| González-Navarro, H | 1 |
| Winter, MP | 1 |
| Wiesbauer, F | 1 |
| Alimohammadi, A | 1 |
| Blessberger, H | 1 |
| Pavo, N | 1 |
| Schillinger, M | 1 |
| Huber, K | 1 |
| Wojta, J | 1 |
| Lang, IM | 1 |
| Maurer, G | 1 |
| Goliasch, G | 1 |
| Zhang, RN | 1 |
| Zheng, RD | 1 |
| Mi, YQ | 1 |
| Zhou, D | 1 |
| Shen, F | 1 |
| Chen, GY | 1 |
| Zhu, CY | 1 |
| Pan, Q | 1 |
| Fan, JG | 1 |
| Vaziri, ND | 1 |
| Christiansen, MK | 1 |
| Jensen, JM | 1 |
| Brøndberg, AK | 1 |
| Bøtker, HE | 1 |
| Jensen, HK | 1 |
| Gao, L | 1 |
| Wang, HN | 1 |
| Zhang, L | 1 |
| Peng, FY | 1 |
| Jia, Y | 1 |
| Wei, W | 1 |
| Jia, LH | 1 |
| Myers, RH | 1 |
| Pankow, JS | 1 |
| Province, MA | 1 |
| Mekki, K | 1 |
| Prost, J | 1 |
| Remaoun, M | 1 |
| Belleville, J | 1 |
| Bouchenak, M | 1 |
| Conklin, DJ | 1 |
| Barski, OA | 1 |
| Lesgards, JF | 1 |
| Juvan, P | 1 |
| Rezen, T | 1 |
| Rozman, D | 1 |
| Prough, RA | 1 |
| Vladykovskaya, E | 1 |
| Liu, S | 1 |
| Srivastava, S | 1 |
| Bhatnagar, A | 1 |
| Kashani Farid, MA | 1 |
| Azizi, F | 1 |
| Hedayati, M | 1 |
| Daneshpour, MS | 1 |
| Shamshiri, AR | 1 |
| Siassi, F | 1 |
| Johnston, TP | 1 |
| Zhang, Y | 1 |
| Klein, K | 1 |
| Sugathan, A | 1 |
| Nassery, N | 1 |
| Dombkowski, A | 1 |
| Zanger, UM | 1 |
| Waxman, DJ | 1 |
| Mangravite, LM | 1 |
| Chiu, S | 1 |
| Wojnoonski, K | 1 |
| Rawlings, RS | 1 |
| Bergeron, N | 1 |
| Krauss, RM | 1 |
| Wild, RA | 1 |
| Vaidya, H | 1 |
| Prajapati, A | 1 |
| Rajani, M | 1 |
| Sudarsanam, V | 1 |
| Padh, H | 1 |
| Goyal, RK | 1 |
| Bie, J | 1 |
| Zhao, B | 2 |
| Marqueen, KE | 1 |
| Wang, J | 1 |
| Szomju, B | 1 |
| Ghosh, S | 1 |
| Ampuero, J | 1 |
| Romero-Gómez, M | 1 |
| Foulkes, AS | 2 |
| DeGruttola, VG | 1 |
| Nonyane, BA | 1 |
| Krarup, NT | 1 |
| Grarup, N | 1 |
| Banasik, K | 1 |
| Friedrichsen, M | 1 |
| Færch, K | 1 |
| Sandholt, CH | 1 |
| Jørgensen, T | 1 |
| Poulsen, P | 1 |
| Witte, DR | 1 |
| Vaag, A | 1 |
| Sørensen, T | 1 |
| Pedersen, O | 1 |
| Hansen, T | 1 |
| Lian, J | 1 |
| Quiroga, AD | 1 |
| Li, L | 1 |
| Lehner, R | 1 |
| De Vries, R | 1 |
| Wolffenbuttel, BH | 1 |
| Sluiter, WJ | 1 |
| van Tol, A | 1 |
| Dullaart, RP | 1 |
| Nelson, RH | 1 |
| Miles, JM | 1 |
| Stancáková, A | 1 |
| Baldaufová, L | 1 |
| Javorský, M | 1 |
| Kozárová, M | 1 |
| Salagovic, J | 1 |
| Tkác, I | 1 |
| Ahmad, I | 1 |
| Ruby, E | 1 |
| Usman, H | 1 |
| Hotiana, M | 1 |
| Hussain, M | 1 |
| Rahman, F | 1 |
| Chhabria, MT | 1 |
| Suhagia, BN | 1 |
| Brahmkshatriya, PS | 1 |
| Sheng, L | 1 |
| Qian, Z | 1 |
| Shi, Y | 1 |
| Yang, L | 1 |
| Xi, L | 1 |
| Xu, X | 1 |
| Ji, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| Lipoprotein Effects of Substituting Beef Protein for Carbohydrate[NCT00852267] | 67 participants (Actual) | Interventional | 2008-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for 1-anilino-8-naphthalenesulfonate and Dyslipidemias
| Article | Year |
|---|---|
Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches.
Topics: Acyltransferases; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dysli | 2021 |
Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
Topics: Dyslipidemias; Humans; Hyperglycemia; Hypertension; Lipase; Membrane Proteins; Metabolic Syndrome; N | 2018 |
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Dyslipidemias; Ezetimibe | 2018 |
Pleiotropic regulation of mitochondrial function by adipose triglyceride lipase-mediated lipolysis.
Topics: Adipose Tissue; Animals; Dyslipidemias; Humans; Lipase; Lipolysis; Liver; Macrophages; Mitochondria; | 2014 |
Cholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemia.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Cardiovascular Diseases; Cholestero | 2014 |
[The role of gut microbiota in the pathogenesis of obesity].
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Diabetes Mellitus, Type 2; Diet; Disease Models | 2014 |
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
Topics: Cholesterol; Creatinine; Dyslipidemias; Humans; Lipase; Lipoproteins; Liver; Nephrotic Syndrome; Pro | 2016 |
Dyslipidemia in PCOS.
Topics: Androgens; Animals; Apolipoproteins; Dyslipidemias; Female; Humans; Lipase; Lipoproteins, LDL; Polyc | 2012 |
[Influence of non-alcoholic fatty liver disease on cardiovascular disease].
Topics: Apolipoprotein C-III; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Chol | 2012 |
The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation.
Topics: Body Mass Index; Case-Control Studies; Cholesterol; Denmark; Dyslipidemias; Fasting; Female; Gene Fr | 2012 |
The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes.
Topics: Anti-Obesity Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Dysli | 2005 |
HDL elevation and lipid lowering therapy: current scenario and future perspectives.
Topics: Animals; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; | 2007 |
3 trials available for 1-anilino-8-naphthalenesulfonate and Dyslipidemias
| Article | Year |
|---|---|
LIPG SNPs, their haplotypes and gene-environment interactions on serum lipid levels.
Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein A-I; Apolipoprotein B-100; China; Cholesterol, HDL; C | 2019 |
Decreased lipases and fatty acid and glycerol transporter could explain reduced fat in diabetic morbidly obese.
Topics: Adiposity; Adult; Aquaporins; Biological Transport; CD36 Antigens; Diabetes Mellitus, Type 2; Down-R | 2014 |
Changes in atherogenic dyslipidemia induced by carbohydrate restriction in men are dependent on dietary protein source.
Topics: Adolescent; Animals; Apolipoproteins B; Cattle; Cholesterol, LDL; Cross-Over Studies; Diet, Atheroge | 2011 |
26 other studies available for 1-anilino-8-naphthalenesulfonate and Dyslipidemias
| Article | Year |
|---|---|
The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells.
Topics: Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Drug Evaluation, Preclinical; Dyslipidemias | 2021 |
A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Diabetes Mellitus; Dyslipid | 2020 |
Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.
Topics: Adult; Aged; Apolipoproteins E; Cholesterol, LDL; Cohort Studies; Dyslipidemias; Exome; Female; Foll | 2014 |
ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys.
Topics: Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Angiopoietins; Animals; Antibodies, Monoclo | 2015 |
HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study.
Topics: Apolipoprotein A-I; ATP Binding Cassette Transporter 1; Cholesterol Ester Transfer Proteins; Cholest | 2015 |
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.
Topics: Alleles; Antiretroviral Therapy, Highly Active; Atherosclerosis; Cholesterol Ester Transfer Proteins | 2015 |
Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.
Topics: Animals; Blood Glucose; Chemokine CCL2; Diet, High-Fat; Dyslipidemias; Glucose Intolerance; Inflamma | 2015 |
Soluble galectin-3 is associated with premature myocardial infarction.
Topics: Adult; Biomarkers; Blood Proteins; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, | 2016 |
APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
Topics: Adult; Alanine Transaminase; Apolipoprotein C-III; Asian People; Body Mass Index; Case-Control Studi | 2016 |
Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.
Topics: Adult; Age of Onset; Antihypertensive Agents; Biomarkers; Blood Pressure; Body Mass Index; Cholester | 2016 |
Effect of Perinatal Bisphenol A Exposure on Serum Lipids and Lipid Enzymes in Offspring Rats of Different Sex.
Topics: Adiponectin; Adipose Tissue; Animals; Benzhydryl Compounds; Body Weight; Dyslipidemias; Female; Huma | 2016 |
LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion.
Topics: Adult; Aged; Cholesterol, HDL; Dyslipidemias; Female; Gene Frequency; Haplotypes; Humans; Introns; L | 2009 |
Long term hemodialysis aggravates lipolytic activity reduction and very low density, low density lipoproteins composition in chronic renal failure patients.
Topics: Adult; Apolipoprotein C-II; Apolipoprotein C-III; Atherosclerosis; Biomarkers; Cholesterol; Dyslipid | 2009 |
Acrolein consumption induces systemic dyslipidemia and lipoprotein modification.
Topics: Acrolein; Animals; Apolipoproteins E; Dose-Response Relationship, Drug; Drug Administration Routes; | 2010 |
Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study.
Topics: Adult; Aged; Aged, 80 and over; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cohort Studie | 2010 |
Poloxamer 407 as a general lipase inhibitor: its implications in lipid metabolism and atheroma formation in C57BL/6 mice.
Topics: Animals; Atherosclerosis; Dyslipidemias; Humans; Intercellular Adhesion Molecule-1; Lipase; Lipid Me | 2010 |
Transcriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery disease.
Topics: Adult; Aged; Animals; Apolipoprotein A-V; Apolipoproteins A; ATP Binding Cassette Transporter 1; ATP | 2011 |
Beneficial effects of swertiamarin on dyslipidaemia in streptozotocin-induced type 2 diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dyslipidemias; G | 2012 |
Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice.
Topics: Animals; Basal Metabolism; Dyslipidemias; Glucose Intolerance; Hepatitis; Insulin Resistance; Kupffe | 2012 |
A resampling-based approach to multiple testing with uncertainty in phase.
Topics: Algorithms; Antiretroviral Therapy, Highly Active; Cholesterol, HDL; Computer Simulation; Dyslipidem | 2007 |
Multiple imputation and random forests (MIRF) for unobservable, high-dimensional data.
Topics: Anti-HIV Agents; Apolipoproteins; Cohort Studies; Computer Simulation; Data Interpretation, Statisti | 2007 |
Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice.
Topics: Animals; Aorta; Apolipoproteins B; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, V | 2012 |
Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
Topics: Case-Control Studies; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dyslipidemias; Heparin; Humans; L | 2005 |
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.
Topics: Aged; Apolipoprotein C-III; Apolipoproteins B; Cholesterol; Cholesterol Ester Transfer Proteins; Cho | 2006 |
Ezetimibe-induced acute pancreatitis.
Topics: Anticholesteremic Agents; Azetidines; Diagnosis, Differential; Dyslipidemias; Ezetimibe; Female; Fol | 2007 |
Crocetin improves the insulin resistance induced by high-fat diet in rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Carotenoids; Dietary Fats; | 2008 |